| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President And COO | President And CEO
4 companies
Swisher Daniel N Jr is a President And CEO at VIRX with holdings across 4 companies. Recent SEC Form 4 filings include 0 buys and 11 sells.
Estimated insider holdings value: $13.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 10, 2025 | CORT Corcept Therapeutics Inc | Director | Sale+OE | 2,200 | $87.54 | $192,588.00 | -100% | -50.6% | - | |
| Sep 10, 2025 | CORT Corcept Therapeutics Inc | Director | Sale+OE | 2,200 | $72.45 | $159,390.00 | -100% | +16.1% | - | |
| Aug 11, 2025 | CORT Corcept Therapeutics Inc | Director | Sale+OE | 2,200 | $72.30 | $159,060.00 | -100% | +4.9% | - | |
| Jul 10, 2025 | CORT Corcept Therapeutics Inc | Director | Sale+OE | 2,200 | $71.08 | $156,376.00 | -100% | +22.8% | - | |
| Jun 10, 2025 | CORT Corcept Therapeutics Inc | Director | Sale+OE | 2,200 | $70.61 | $155,342.00 | -100% | -1.4% | - | |
| May 12, 2025 | CORT Corcept Therapeutics Inc | Director | Sale+OE | 2,200 | $72.06 | $158,526.00 | -84.6% | -0.2% | - | |
| Apr 10, 2025 | CORT Corcept Therapeutics Inc | Director | Sale+OE | 2,200 | $70.22 | $154,484.00 | -100% | +4.7% | -38.1% | |
| Mar 10, 2025 | CORT Corcept Therapeutics Inc | Director | Sale+OE | 2,200 | $53.60 | $117,920.00 | -100% | +25.1% | -40.5% | |
| Feb 10, 2025 | CORT Corcept Therapeutics Inc | Director | Sale+OE | 2,200 | $68.08 | $149,776.00 | -100% | +6.8% | -39.3% | |
| Jan 10, 2025 | CORT Corcept Therapeutics Inc | Director | Sale+OE | 2,200 | $50.54 | $111,188.00 | -100% | +35.9% | -24.8% |